Nanae Harashima

2.2k total citations
48 papers, 1.8k citations indexed

About

Nanae Harashima is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Nanae Harashima has authored 48 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 17 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Nanae Harashima's work include Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (12 papers) and T-cell and Retrovirus Studies (10 papers). Nanae Harashima is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (12 papers) and T-cell and Retrovirus Studies (10 papers). Nanae Harashima collaborates with scholars based in Japan, United States and Malaysia. Nanae Harashima's co-authors include Mamoru Harada, Miki Tongu, Mari Kannagi, Takaya Yamada, Elena Cherkasova, Yoshiyuki Takahashi, Ramaprasad Srinivasan, Michael I. Lerman, Kiyoshi Kurihara and Hisayuki Yokoyama and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Nanae Harashima

48 papers receiving 1.8k citations

Peers

Countries citing papers authored by Nanae Harashima

Since Specialization

Citations

This map shows the geographic impact of Nanae Harashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanae Harashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanae Harashima more than expected).

Fields of papers citing papers by Nanae Harashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanae Harashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanae Harashima. The network helps show where Nanae Harashima may publish in the future.

Co-authorship network of co-authors of Nanae Harashima

This figure shows the co-authorship network connecting the top 25 collaborators of Nanae Harashima. A scholar is included among the top collaborators of Nanae Harashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanae Harashima. Nanae Harashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer 2016 ·Cancer Research ·Elena Cherkasova, (unknown), (unknown), (unknown), Yoshiyuki Takahashi, Nanae Harashima, Hisayuki Yokoyama, Ramaprasad Srinivasan, W. Marston Linehan, Michael I. Lerman, Richard Childs	92
2	The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells 2015 ·PLoS ONE ·Min Zhang, Nanae Harashima, (unknown), Weidong Huang, Mamoru Harada	77
3	New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles 2015 ·International Immunopharmacology ·Takafumi Minami, (unknown), (unknown), Nobutaka Shimizu, Yutaka Yamamoto, Marco A. De Velasco, Masahiro Nozawa, Kazuhiro Yoshimura, Nanae Harashima, Mamoru Harada, Hirotsugu Uemura	3
4	The HSP70 and Autophagy Inhibitor Pifithrin-μ Enhances the Antitumor Effects of TRAIL on Human Pancreatic Cancer 2013 ·Molecular Cancer Therapeutics ·(unknown), Nanae Harashima, Touko Inao, Shinji Okano, Yoshitsugu Tajima, Mamoru Harada	38
5	Pifithrin-μ, an Inhibitor of Heat-Shock Protein 70, Can Increase the Antitumor Effects of Hyperthermia Against Human Prostate Cancer Cells 2013 ·PLoS ONE ·Kazumasa Sekihara, Nanae Harashima, Miki Tongu, Yukihisa Tamaki, Nobue Uchida, T Inomata, Mamoru Harada	44
6	Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells 2011 ·Cancer Immunology Immunotherapy ·Nanae Harashima, (unknown), Ryu Imamura, Shinji Okano, Takashi Suda, Mamoru Harada	58
7	Oral ingestion of Lentinula edodes mycelia extract inhibits B16 melanoma growth via mitigation of regulatory T cell‐mediated immunosuppression 2011 ·Cancer Science ·(unknown), Satoru Ishikawa, (unknown), Makoto Tamesada, Nanae Harashima, Mamoru Harada	25
8	Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma 2009 ·Cancer Immunology Immunotherapy ·Miki Tongu, Nanae Harashima, Takaya Yamada, Takayuki Harada, Mamoru Harada	46
9	The human endogenous retrovirus (HERV) derived kidney Cancer antigen CT-RCC1 induces proliferation of CD8+ antigen-specific T-cells in vitro that kill renal cell carcinoma (RCC) and is up-regulated by inhibiting histone deacetylase 2008 ·Cancer Research ·Sheila Rao, Abdul Tawab, Roger Kurlander, Nanae Harashima, Andreas Lundqvist, Julie A. Hong, (unknown), (unknown), Elena Cherkasova, Philip McCoy, David S. Schrump, Richard Childs	2
10	Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathies 2008 ·Immunology ·Masahiro Kondo, Yohko Murakawa, Nanae Harashima, Shotai Kobayashi, Shuhei Yamaguchi, Mamoru Harada	33
11	Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells 2008 ·Journal of Clinical Investigation ·Yoshiyuki Takahashi, Nanae Harashima, Sachiko Kajigaya, Hisayuki Yokoyama, Elena Cherkasova, J. Philip McCoy, Ken‐ichi Hanada, Othon J. Mena, Roger Kurlander, Abdul Tawab, Ramaprasad Srinivasan, Andreas Lundqvist, (unknown), Nancy L. Geller, Michael I. Lerman, Richard Childs	152
12	Impaired Tax‐specific T‐cell responses with insufficient control of HTLV‐1 in a subgroup of individuals at asymptomatic and smoldering stages 2008 ·Cancer Science ·(unknown), (unknown), Atae Utsunomiya, (unknown), Yoshihisa Yamano, Masakatsu Hishizawa, Atsuhiko Hasegawa, (unknown), Kiyoshi Kurihara, Nanae Harashima, Toshiki Watanabe, Jun Okamura, Takao Masuda, Mari Kannagi	16
13	Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins 2006 ·Journal of Immunological Methods ·Kiyoshi Kurihara, (unknown), (unknown), Nanae Harashima, (unknown), Takao Masuda, Atae Utsunomiya, Jun Okamura, Mari Kannagi	7
14	Adult T-cell leukemia: future prophylaxis and immunotherapy 2004 ·Expert Review of Anticancer Therapy ·Mari Kannagi, Nanae Harashima, Kiyoshi Kurihara, Atae Utsunomiya, Ryuji Tanosaki, Masato Masuda	16
15	Potential immunogenicity of adult T cell leukemia cells in vivo 2004 ·International Journal of Cancer ·Kiyoshi Kurihara, Nanae Harashima, Shino Hanabuchi, Masato Masuda, Atae Utsunomiya, Ryuji Tanosaki, Masao Tomonaga, Takashi Ohashi, Atsuhiko Hasegawa, Takao Masuda, Jun Okamura, Yuetsu Tanaka, Mari Kannagi	41
16	Reactivation of strong HTLV-I-specific CTL response in ATL patients following non-myeloablative hematopoietic stem cell transplantation. 2003 ·AIDS Research and Human Retroviruses ·Nanae Harashima, Kazuo Kurihara, Atae Utsunomiya, Ryuji Tanosaki, Shino Hanabuchi, M Masuda, Takashi Ohashi, Aiko Hasegawa, (unknown), Yoichi Takaue, (unknown), Mari Kannagi	1
17	Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients 2002 ·Japanese Journal of Cancer Research ·Koji Tanaka, Nanae Harashima, Fumihiko Niiya, (unknown), Naoya Hida, (unknown), (unknown), Mamoru Harada, Kyogo Itoh, Shigeki Shichijo	6
18	Cleavage and polyadenylation specificity factor (CPSF)‐derived peptides can induce HLA‐A2‐restricted and tumor‐specific CTLs in the majority of gastrointestinal cancer patients 2002 ·International Journal of Cancer ·Yoshiaki Maeda, Masaaki Ito, Nanae Harashima, Tetsuya Nakatsura, Naoya Hida, (unknown), Yuuji Sato, Shigeki Shichijo, Satoru Todo, Kyogo Itoh	15
19	Identification of Cyclophilin B‐derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen‐A2‐restricted and Tumor‐specific Cytotoxic T Lymphocytes 2001 ·Japanese Journal of Cancer Research ·Mayumi Tamura, (unknown), Yoshiaki Maeda, Masaaki Ito, Nanae Harashima, Mamoru Harada, Shigeki Shichijo, Kyogo Itoh	24
20	Study of HLA class I restriction and the directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer 1999 ·Cancer Immunology Immunotherapy ·Akira Yamada, K. Kawano, Nanae Harashima, Fumihiko Niiya, (unknown), (unknown), Takashi Mine, Kimio Ushijima, Takashi Nishida, Kyogo Itoh	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact